PubMed:18199556 / 461-679 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/18199556","sourcedb":"PubMed","sourceid":"18199556","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/18199556","text":"Hsp90 inhibitors, such as 17-allylamino-17-demethoxygeldanamycin (17-AAG), induce the degradation of EGFR and other Hsp90 interacting proteins and may thus have utility in tumors dependent upon sensitive Hsp90 clients.","tracks":[{"project":"PMID_GLOBAL","denotations":[{"id":"T3","span":{"begin":194,"end":203},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0000605"},{"subj":"T3","pred":"source","obj":"PMID_GLOBAL"}]},{"project":"sentences","denotations":[{"id":"TextSentencer_T4","span":{"begin":0,"end":218},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":218},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T4","pred":"source","obj":"sentences"},{"subj":"T4","pred":"source","obj":"sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"PMID_GLOBAL","color":"#ecae93","default":true},{"id":"sentences","color":"#9493ec"}]}]}}